Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib for Cancer Pain
NCT00095017Phase 2Withdrawn
- Sponsor
- Organon & Co.
- Start
- Nov 2004
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of etoricoxib in cancer pain, sponsored by Organon & Co.. Planned start Nov 2004; status: withdrawn.
02
Drugs
etoricoxib
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT00095017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00095017.